Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 20, 2012.
Article Versions
- Latest version (June 15, 2012 - 04:00).
- You are currently viewing a Latest version of this article (June 20, 2012 - 13:14).
- View the most recent version of this article
Copyright & Usage
© 2012 The Journal of Rheumatology
Author Information
- W. Winn Chatham,
- Daniel J. Wallace,
- William Stohl,
- Kevin M. Latinis,
- Susan Manzi,
- W. Joseph McCune,
- Dana Tegzová,
- James D. McKay,
- Hilario E. Avila-Armengol,
- Tammy O. Utset,
- Z. John Zhong,
- Douglas R. Hough,
- William W. Freimuth,
- Thi-Sau Migone and
- on behalf of the BLISS-76 Study Group
- From the Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Cedars-Sinai Medical Center, Los Angeles, California; Division of Rheumatology, Los Angeles County + University of Southern California Medical Center and University of Southern California Keck School of Medicine, Los Angeles, California; Internal Medicine, Division of Rheumatology, University of Kansas Medical Center, Kansas City, Kansas; Department of Medicine, West Penn Allegheny Health System, Temple University School of Medicine, Pittsburgh, Pennsylvania; Internal Medicine, Division of Rheumatology, University of Michigan Medical Center — Regents of the University of Michigan, Ann Arbor, Michigan, USA; Institute of Rheumatology, Prague, Czech Republic; Oklahoma Center for Arthritis Therapy and Research, Tulsa, Oklahoma, USA; Instituto Jalisciense de Investigación Clínica, Guadalajara, Jalisco, Mexico; Internal Medicine, Division of Rheumatology, University of Chicago Pritzker School of Medicine, Chicago, Illinois; and Human Genome Sciences Inc., Rockville, Maryland, USA.
Supported by Human Genome Sciences Inc. (HGS), Rockville, Maryland, and GlaxoSmithKline (GSK), Uxbridge, Middlesex, United Kingdom. Dr. Chatham has received research or grant support and travel support from HGS. Drs. Wallace and Latinis have received consulting fees, speaking fees, and/or honoraria from HGS and GSK. Dr. Stohl has received clinical trial support from HGS. Dr. Manzi has received research grants and consulting fees from HGS. Dr. McCune has received research grants from HGS. Dr. Tegzová has received clinical trial support from HGS. Dr. McKay owns stock in HGS. Dr. Avila-Armengol has received clinical trial support from HGS. Dr. Utset has received speaking honoraria for general SLE lay education. Drs. Zhong, Hough, Freimuth, and Migone are employed by and own stock in HGS. Editorial support was funded by Human Genome Sciences and GlaxoSmithKline.
W.W. Chatham, MD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; D.J. Wallace, MD, Cedars-Sinai Medical Center; W. Stohl, MD, PhD, Division of Rheumatology, Los Angeles County + University of Southern California Medical Center and University of Southern California Keck School of Medicine; K.M. Latinis, MD, PhD, Internal Medicine, Division of Rheumatology, University of Kansas Medical Center; S. Manzi, MD, MPH, Department of Medicine, West Penn Allegheny Health System, Temple University School of Medicine; W.J. McCune, MD, Internal Medicine, Division of Rheumatology, University of Michigan Medical Center — Regents of the University of Michigan; D. Tegzová, MD, Institute of Rheumatology, Prague; J.D. McKay, DO, Oklahoma Center for Arthritis Therapy and Research; H.E. Avila-Armengol, MD, Instituto Jalisciense de Investigación Clínica; T.O. Utset, MD, Internal Medicine, Division of Rheumatology, University of Chicago Pritzker School of Medicine; Z.J. Zhong, PhD; D.R. Hough, MD; W.W. Freimuth, MD, PhD; T-S. Migone, PhD, Human Genome Sciences.
Address correspondence to Dr. W.W. Chatham, Rheumatology FOT 802, University of Alabama-Birmingham, 1530 3rd Ave. South, Birmingham, AL 35294, USA. E-mail: wchatham@uab.edu
Full Release Article. For details see Reprint/Permissions at jrheum.org Accepted for publication April 16, 2012.